| 引用本文: | 黄小红,黄涓涓,林小燕,刘茂柏,林立.21例新型冠状病毒肺炎患者药物治疗方案的回顾性分析[J].中国现代应用药学,2022,39(20):2640-2644. |
| HUANG Xiaohong,HUANG Juanjuan,LIN Xiaoyan,LIU Maobai,LIN Li.Retrospective Analysis of 21 COVID-19 Patients’ Therapeutic Regimen[J].Chin J Mod Appl Pharm(中国现代应用药学),2022,39(20):2640-2644. |
|
| 摘要: |
| 目的 对21例治愈出院的新型冠状病毒肺炎患者的治疗方案进行评价分析，为后续病例的诊治提供参考。方法 回顾性分析2020年2—4月治愈出院的新型冠状病毒肺炎患者的病例资料及药物治疗方案。结果 所有确诊患者均有流行病学史，以普通型(90.5%)为主，依据诊疗方案给予抗病毒治疗和其他支持治疗，疗效和安全性良好，所有患者均治愈出院。结论 临床药师应追踪新型冠状病毒肺炎研究进展，参与方案制定，针对患者个体化情况，提出药学建议，保证患者的安全合理用药。 |
| 关键词: 新型冠状病毒肺炎 药物治疗 抗病毒 回顾性分析 |
| DOI：10.13748/j.cnki.issn1007-7693.2022.20.011 |
| 分类号:R969.3 |
| 基金项目: |
|
| Retrospective Analysis of 21 COVID-19 Patients’ Therapeutic Regimen |
|
HUANG Xiaohong1, HUANG Juanjuan1, LIN Xiaoyan1, LIU Maobai2, LIN Li3
|
|
1.Zhangzhou Affiliated Hospital of Fujian Medical University, Department of Pharmacy, Zhangzhou 363000, China;2.Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou 350001, China;3.Zhangzhou Affiliated Hospital of Fujian Medical University, Department of Respiratory and Critical Care Medicine, Zhangzhou 363000, China
|
| Abstract: |
| OBJECTIVE To evaluate the medical treatment of 21 COVID-19 discharged patients, and provide reference for the diagnosis and treatment of follow-up cases.METHODS Retrospectively analyzed the case data and medical treatment of COVID-19 patients who were discharged from February 2020 to April 2020.RESULTS All the patients had an epidemiological history, the mainly type was common(90.5%). Antiviral treatment and other supportive treatment were given, with good efficacy and safety. All patients were cured and discharged.CONCLUSION Clinical pharmacists should actively participate in the formulation of therapeutic regimen for COVID-19. The pharmaceutical suggestions are put forward to ensure the rational use of drugs and safety. |
| Key words: COVID-19 medical treatment antiviral retrospective analysis |
